Skip to main content
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Articles
ASCO 2019 - Chronic Lymphocytic Leukemia
Smart Start: Final Results of Rituximab, Lenalidomide, and Ibrutinib Lead-In Therapy for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma
Read More
ASCO 2019 - Chronic Lymphocytic Leukemia
Phase 2 Study of Acalabrutinib in Ibrutinib-Intolerant Patients with Relapsed/Refractory CLL
Read More
ASCO 2019 - Chronic Lymphocytic Leukemia
Conceptual Model of CLL
Read More
ASCO 2019 - Chronic Lymphocytic Leukemia
A Systematic Review of the Efficacy of Ibrutinib-Based Combination Therapy for Mantle-Cell Lymphoma
Read More
ASCO 2019 - Chronic Lymphocytic Leukemia
SYK Inhibition with Fostamatinib in Waldenström’s Macroglobulinemia
Read More
ASCO 2019 - Chronic Lymphocytic Leukemia
Ibrutinib Maintenance Following Induction for Untreated MCL: Initial Safety Report
Read More
ASCO 2019 - Chronic Lymphocytic Leukemia
Phase 1/2 Trial of Cirmtuzumab plus Ibrutinib: Planned Analysis of Phase 1 CLL Cohorts
Read More
ASCO 2019 - Chronic Lymphocytic Leukemia
The ZUMA-8 Phase 1/2 Multicenter Study Evaluating KTE-X19 in Patients with Relapsed/Refractory CLL
Read More
ASCO 2019 - Chronic Lymphocytic Leukemia
A Phase 2 Study Investigating Umbralisib Monotherapy in Patients with Relapsed/Refractory MZL
Read More
ASCO 2019 - Chronic Lymphocytic Leukemia
Final Analysis from RESONATE: Six-Year Follow-Up in Patients with Previously Treated CLL/SLL Receiving Ibrutinib
Read More
49
50
51
52
53
54
55
Page 52 of 244
Results 511 - 520 of 2436
